AT
ABBV icon

Adelphi Trust’s AbbVie ABBV Stock Holding History

Adelphi Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.79M Buy
10,668
+204
+2% +$52.3K 1.84% 14
2026
Q2 		$2.63M Buy
10,464
+816
+8% +$176K 1.75% 15
2026
Q1 		$2.1M Buy
9,648
+374
+4% +$83K 1.71% 16
2025
Q4 		$2.12M Buy
+9,274
New +$2.11M 1.73% 16

Other funds holding ABBV

FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Violich Capital Management San Francisco, California $927M AUM 28.93% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.07B AUM 21.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
PWM
Pacific Wealth Management San Diego, California $227M AUM 24.81% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return

Adelphi Trust's ABBV Position: Q3 2026 in Review

Adelphi Trust increased its AbbVie (ABBV) stake by 1.9% in Q3 2026, buying an estimated $52.3K and bringing the position to 10,668 shares worth $2.79M. The position accounts for 1.84% of the portfolio, ranked #14.

Adelphi Trust first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 47 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Adelphi Trust held 10,668 shares of AbbVie worth $2.79M as of Q3 2026.
  • Adelphi Trust bought 204 AbbVie shares in Q3 2026, an estimated $52.3K.
  • AbbVie made up 1.84% of Adelphi Trust's portfolio in Q3 2026, its #14 holding.
  • Adelphi Trust first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 47 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Adelphi Trust's 13F filing for Q3 2026, filed 5 Oct 2026.